Amber Mael
Works at
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R44Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cellsR44DK1330082022–20276 Aug 2026reporter.nih.gov